Galafold
Ended Awarded
- Contract number
- 36C24925N0624
- Awardee
-
Amicus Therapeutics US, LLC UEI KLJFGENKMD89
- Awarding agency
-
Veterans Integrated Service Network 9
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $65,674
Award facts
- Contract value 100% obligated
- $65,673.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Philadelphia, PA 19104, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award (ID: 36F79724D0185|36C24925N0624) was issued by the Department of Veterans Affairs (VA) to Amicus Therapeutics US, LLC, a biopharmaceutical company focused on rare genetic diseases. The $65,673.63 firm fixed-price delivery order is for the pharmaceutical product Galafold (migalastat) 123 mg, an enzyme replacement therapy used to treat Fabry disease.
The award is part of Amicus Therapeutics US, LLC's $13,024,630 Federal Supply Schedule (FSS) contract (36F79724D0185) with the VA under the Pharmaceuticals and Drugs (FSS-61-IB) schedule. This multiple-award, firm-fixed-price contract has a period of performance through August 31, 2029 and enables various VA Veterans Integrated Service Networks to efficiently procure specialized pharmaceutical products. The contract did not have a set-aside designation.
Quick answers
Who was awarded contract 36C24925N0624?
36C24925N0624 was awarded to Amicus Therapeutics US, LLC by Veterans Integrated Service Network 9 (Veterans Health Administration) on June 27, 2025.
How much is contract 36C24925N0624 worth?
The government has obligated $65,674 on 36C24925N0624.
Is contract 36C24925N0624 an order under another contract?
Yes. 36C24925N0624 is a delivery order under 36F79724D0185, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24925N0624 competed?
The extent of competition for 36C24925N0624 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award